These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 27616330)

  • 1. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
    Völzke A; Koch A; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2014 Jan; 1841(1):11-21. PubMed ID: 24064301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
    Pan MR; Hou MF; Chang HC; Hung WC
    J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
    Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
    Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
    J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP2/4 Receptors Promote the Synthesis of PGE
    Zhang C; Wang L; Li T; Mao W; Liu B; Cao J
    J Pharmacol Exp Ther; 2020 Feb; 372(2):175-184. PubMed ID: 31732699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.
    Harizi H; Limem I; Gualde N
    Immunol Cell Biol; 2011 Feb; 89(2):275-82. PubMed ID: 20697426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate induces COX-2 expression and PGE2 production in human granulosa cells through a S1P1/3-mediated YAP signaling.
    Cheng JC; Chang HM; Liu PP; Leung PC
    Cell Signal; 2016 Jun; 28(6):643-51. PubMed ID: 26994820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP4 receptor promotes invadopodia and invasion in human breast cancer.
    Tönisen F; Perrin L; Bayarmagnai B; van den Dries K; Cambi A; Gligorijevic B
    Eur J Cell Biol; 2017 Mar; 96(2):218-226. PubMed ID: 28094049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
    Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
    Cells; 2020 May; 9(5):. PubMed ID: 32438662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer.
    Ke J; Yang Y; Che Q; Jiang F; Wang H; Chen Z; Zhu M; Tong H; Zhang H; Yan X; Wang X; Wang F; Liu Y; Dai C; Wan X
    Tumour Biol; 2016 Sep; 37(9):12203-12211. PubMed ID: 27230680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.